Schlesinger launches clinical research brand

Schlesinger Clinical Research will bring together all of the company’s data collection work needed for clinical research.

The new branch of the company will be based across 30 sites and will oversee the recruitment and consistent application of clinical study research protocols, and will initially focus on non-prescription drugs.

Rob Ramirez, executive vice-president Schlesinger Group, said Schlesinger Clinical Research would bring “site selection, subject enrolment and study execution expertise under one partner”.